May 04,2021 Cardea Bio Develops Exosome and Extracellular Vesicles (EV) Detection Technology Called EV-Chip, Showcasing Cancer and Aging Dx Applications read more >>
Apr 28,2021 Aravive Announces First Patient Dosed in Phase 3 Registrational Trial Evaluating AVB-500 in Patients with Platinum Resistant Ovarian Cancer read more >>
Mar 30,2021 Immune-Onc Therapeutics Announces $73 Million in Series B1 and B2 Financing to Advance its Portfolio of Novel Immunotherapies in Blood Cancers and Solid Tumors read more >>
Mar 17,2021 Alveo Technologies' be.well COVID-19 Test Wins XPRIZE Rapid Covid Testing Competition read more >>
Mar 09,2021 Twist Bioscience Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2021 read more >>
Feb 25,2021 CULLGEN CLOSES $50 MILLION SERIES B INVESTMENT TO ADVANCE TARGETED PROTEIN DEGRADERS AND NOVEL E3 LIGANDS PLATFORM read more >>
Jan 13,2021 Cardea Bio Adds $6.5 Million to Series A; Early-Stage Financing Now Totals More Than $20 Million read more >>